img

Global Malaria Prescription Medication Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Malaria Prescription Medication Market Insights, Forecast to 2034

Global Malaria Prescription Medication market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Malaria Prescription Medication industry is evaluated to reach US$ million in 2034. The CAGR will be % during 2024 to 2034.
Globally, Malaria Prescription Medication key manufacturers include Zydus Healthcare, Sun Pharmaceutical Industries Ltd., Sanofi SA, GSK Plc., Novartis AG, Cipla, Viatris, Lupin and Advacare Pharma USA, etc. Zydus Healthcare, Sun Pharmaceutical Industries Ltd., Sanofi SA are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Malaria Prescription Medication were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Malaria Prescription Medication market and estimated to attract more attentions from industry insiders and investors.
Malaria Prescription Medication can be divided into Oral and Parenteral and Intravenous, etc. Oral and Parenteral is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2034.
Malaria Prescription Medication is widely used in various fields, such as Hospitals, Specialty Clinics, Homecare and Others, etc. Hospitals provides greatest supports to the Malaria Prescription Medication industry development. In 2022, global % sales of Malaria Prescription Medication went into Hospitals filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Malaria Prescription Medication market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Malaria Prescription Medication market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Zydus Healthcare
Sun Pharmaceutical Industries Ltd.
Sanofi SA
GSK Plc.
Novartis AG
Cipla
Viatris
Lupin
Advacare Pharma USA
VLP Therapeutics
Segment by Type
Oral and Parenteral
Intravenous

Segment by Application


Hospitals
Specialty Clinics
Homecare
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Malaria Prescription Medication plant distribution, commercial date of Malaria Prescription Medication, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Malaria Prescription Medication introduction, etc. Malaria Prescription Medication Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14QYResearch’s Conclusions of Malaria Prescription Medication
Chapter 15Methodology and Data Sources adopted by QYResearch

Table of Content

1 Study Coverage
1.1 Malaria Prescription Medication Product Introduction
1.2 Market by Type
1.2.1 Global Malaria Prescription Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral and Parenteral
1.2.3 Intravenous
1.3 Market by Application
1.3.1 Global Malaria Prescription Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Malaria Prescription Medication Sales Estimates and Forecasts 2018-2034
2.2 Global Malaria Prescription Medication Revenue by Region
2.2.1 Global Malaria Prescription Medication Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Malaria Prescription Medication Revenue by Region (2018-2024)
2.2.3 Global Malaria Prescription Medication Revenue by Region (2024-2034)
2.2.4 Global Malaria Prescription Medication Revenue Market Share by Region (2018-2034)
2.3 Global Malaria Prescription Medication Sales Estimates and Forecasts 2018-2034
2.4 Global Malaria Prescription Medication Sales by Region
2.4.1 Global Malaria Prescription Medication Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Malaria Prescription Medication Sales by Region (2018-2024)
2.4.3 Global Malaria Prescription Medication Sales by Region (2024-2034)
2.4.4 Global Malaria Prescription Medication Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Malaria Prescription Medication Sales by Manufacturers
3.1.1 Global Malaria Prescription Medication Sales by Manufacturers (2018-2024)
3.1.2 Global Malaria Prescription Medication Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Malaria Prescription Medication in 2022
3.2 Global Malaria Prescription Medication Revenue by Manufacturers
3.2.1 Global Malaria Prescription Medication Revenue by Manufacturers (2018-2024)
3.2.2 Global Malaria Prescription Medication Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Malaria Prescription Medication Revenue in 2022
3.3 Global Key Players of Malaria Prescription Medication, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Malaria Prescription Medication Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Malaria Prescription Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Malaria Prescription Medication, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Malaria Prescription Medication, Product Offered and Application
3.8 Global Key Manufacturers of Malaria Prescription Medication, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Malaria Prescription Medication Sales by Type
4.1.1 Global Malaria Prescription Medication Historical Sales by Type (2018-2024)
4.1.2 Global Malaria Prescription Medication Forecasted Sales by Type (2024-2034)
4.1.3 Global Malaria Prescription Medication Sales Market Share by Type (2018-2034)
4.2 Global Malaria Prescription Medication Revenue by Type
4.2.1 Global Malaria Prescription Medication Historical Revenue by Type (2018-2024)
4.2.2 Global Malaria Prescription Medication Forecasted Revenue by Type (2024-2034)
4.2.3 Global Malaria Prescription Medication Revenue Market Share by Type (2018-2034)
4.3 Global Malaria Prescription Medication Price by Type
4.3.1 Global Malaria Prescription Medication Price by Type (2018-2024)
4.3.2 Global Malaria Prescription Medication Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Malaria Prescription Medication Sales by Application
5.1.1 Global Malaria Prescription Medication Historical Sales by Application (2018-2024)
5.1.2 Global Malaria Prescription Medication Forecasted Sales by Application (2024-2034)
5.1.3 Global Malaria Prescription Medication Sales Market Share by Application (2018-2034)
5.2 Global Malaria Prescription Medication Revenue by Application
5.2.1 Global Malaria Prescription Medication Historical Revenue by Application (2018-2024)
5.2.2 Global Malaria Prescription Medication Forecasted Revenue by Application (2024-2034)
5.2.3 Global Malaria Prescription Medication Revenue Market Share by Application (2018-2034)
5.3 Global Malaria Prescription Medication Price by Application
5.3.1 Global Malaria Prescription Medication Price by Application (2018-2024)
5.3.2 Global Malaria Prescription Medication Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Malaria Prescription Medication Market Size by Type
6.1.1 US & Canada Malaria Prescription Medication Sales by Type (2018-2034)
6.1.2 US & Canada Malaria Prescription Medication Revenue by Type (2018-2034)
6.2 US & Canada Malaria Prescription Medication Market Size by Application
6.2.1 US & Canada Malaria Prescription Medication Sales by Application (2018-2034)
6.2.2 US & Canada Malaria Prescription Medication Revenue by Application (2018-2034)
6.3 US & Canada Malaria Prescription Medication Market Size by Country
6.3.1 US & Canada Malaria Prescription Medication Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Malaria Prescription Medication Sales by Country (2018-2034)
6.3.3 US & Canada Malaria Prescription Medication Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Malaria Prescription Medication Market Size by Type
7.1.1 Europe Malaria Prescription Medication Sales by Type (2018-2034)
7.1.2 Europe Malaria Prescription Medication Revenue by Type (2018-2034)
7.2 Europe Malaria Prescription Medication Market Size by Application
7.2.1 Europe Malaria Prescription Medication Sales by Application (2018-2034)
7.2.2 Europe Malaria Prescription Medication Revenue by Application (2018-2034)
7.3 Europe Malaria Prescription Medication Market Size by Country
7.3.1 Europe Malaria Prescription Medication Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Malaria Prescription Medication Sales by Country (2018-2034)
7.3.3 Europe Malaria Prescription Medication Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Malaria Prescription Medication Market Size
8.1.1 China Malaria Prescription Medication Sales (2018-2034)
8.1.2 China Malaria Prescription Medication Revenue (2018-2034)
8.2 China Malaria Prescription Medication Market Size by Application
8.2.1 China Malaria Prescription Medication Sales by Application (2018-2034)
8.2.2 China Malaria Prescription Medication Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Malaria Prescription Medication Market Size by Type
9.1.1 Asia Malaria Prescription Medication Sales by Type (2018-2034)
9.1.2 Asia Malaria Prescription Medication Revenue by Type (2018-2034)
9.2 Asia Malaria Prescription Medication Market Size by Application
9.2.1 Asia Malaria Prescription Medication Sales by Application (2018-2034)
9.2.2 Asia Malaria Prescription Medication Revenue by Application (2018-2034)
9.3 Asia Malaria Prescription Medication Sales by Region
9.3.1 Asia Malaria Prescription Medication Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Malaria Prescription Medication Revenue by Region (2018-2034)
9.3.3 Asia Malaria Prescription Medication Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Malaria Prescription Medication Market Size by Type
10.1.1 Middle East, Africa and Latin America Malaria Prescription Medication Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Malaria Prescription Medication Market Size by Application
10.2.1 Middle East, Africa and Latin America Malaria Prescription Medication Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Malaria Prescription Medication Sales by Country
10.3.1 Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Malaria Prescription Medication Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Zydus Healthcare
11.1.1 Zydus Healthcare Company Information
11.1.2 Zydus Healthcare Overview
11.1.3 Zydus Healthcare Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Zydus Healthcare Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zydus Healthcare Recent Developments
11.2 Sun Pharmaceutical Industries Ltd.
11.2.1 Sun Pharmaceutical Industries Ltd. Company Information
11.2.2 Sun Pharmaceutical Industries Ltd. Overview
11.2.3 Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments
11.3 Sanofi SA
11.3.1 Sanofi SA Company Information
11.3.2 Sanofi SA Overview
11.3.3 Sanofi SA Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi SA Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi SA Recent Developments
11.4 GSK Plc.
11.4.1 GSK Plc. Company Information
11.4.2 GSK Plc. Overview
11.4.3 GSK Plc. Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 GSK Plc. Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK Plc. Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Information
11.5.2 Novartis AG Overview
11.5.3 Novartis AG Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis AG Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis AG Recent Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Overview
11.6.3 Cipla Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Cipla Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Viatris
11.7.1 Viatris Company Information
11.7.2 Viatris Overview
11.7.3 Viatris Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Viatris Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Viatris Recent Developments
11.8 Lupin
11.8.1 Lupin Company Information
11.8.2 Lupin Overview
11.8.3 Lupin Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Lupin Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lupin Recent Developments
11.9 Advacare Pharma USA
11.9.1 Advacare Pharma USA Company Information
11.9.2 Advacare Pharma USA Overview
11.9.3 Advacare Pharma USA Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Advacare Pharma USA Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Advacare Pharma USA Recent Developments
11.10 VLP Therapeutics
11.10.1 VLP Therapeutics Company Information
11.10.2 VLP Therapeutics Overview
11.10.3 VLP Therapeutics Malaria Prescription Medication Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 VLP Therapeutics Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 VLP Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Malaria Prescription Medication Industry Chain Analysis
12.2 Malaria Prescription Medication Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Malaria Prescription Medication Production Mode & Process
12.4 Malaria Prescription Medication Sales and Marketing
12.4.1 Malaria Prescription Medication Sales Channels
12.4.2 Malaria Prescription Medication Distributors
12.5 Malaria Prescription Medication Customers
13 Market Dynamics
13.1 Malaria Prescription Medication Industry Trends
13.2 Malaria Prescription Medication Market Drivers
13.3 Malaria Prescription Medication Market Challenges
13.4 Malaria Prescription Medication Market Restraints
14 Key Findings in The Global Malaria Prescription Medication Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Malaria Prescription Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oral and Parenteral
Table 3. Major Manufacturers of Intravenous
Table 4. Global Malaria Prescription Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Malaria Prescription Medication Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Malaria Prescription Medication Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Malaria Prescription Medication Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Malaria Prescription Medication Revenue Market Share by Region (2018-2024)
Table 9. Global Malaria Prescription Medication Revenue Market Share by Region (2024-2034)
Table 10. Global Malaria Prescription Medication Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Malaria Prescription Medication Sales by Region (2018-2024) & (K Units)
Table 12. Global Malaria Prescription Medication Sales by Region (2024-2034) & (K Units)
Table 13. Global Malaria Prescription Medication Sales Market Share by Region (2018-2024)
Table 14. Global Malaria Prescription Medication Sales Market Share by Region (2024-2034)
Table 15. Global Malaria Prescription Medication Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Malaria Prescription Medication Sales Share by Manufacturers (2018-2024)
Table 17. Global Malaria Prescription Medication Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Malaria Prescription Medication Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Malaria Prescription Medication, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Malaria Prescription Medication Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Malaria Prescription Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Malaria Prescription Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Prescription Medication as of 2022)
Table 23. Global Key Manufacturers of Malaria Prescription Medication, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Malaria Prescription Medication, Product Offered and Application
Table 25. Global Key Manufacturers of Malaria Prescription Medication, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Malaria Prescription Medication Sales by Type (2018-2024) & (K Units)
Table 28. Global Malaria Prescription Medication Sales by Type (2024-2034) & (K Units)
Table 29. Global Malaria Prescription Medication Sales Share by Type (2018-2024)
Table 30. Global Malaria Prescription Medication Sales Share by Type (2024-2034)
Table 31. Global Malaria Prescription Medication Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Malaria Prescription Medication Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Malaria Prescription Medication Revenue Share by Type (2018-2024)
Table 34. Global Malaria Prescription Medication Revenue Share by Type (2024-2034)
Table 35. Malaria Prescription Medication Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Malaria Prescription Medication Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Malaria Prescription Medication Sales by Application (2018-2024) & (K Units)
Table 38. Global Malaria Prescription Medication Sales by Application (2024-2034) & (K Units)
Table 39. Global Malaria Prescription Medication Sales Share by Application (2018-2024)
Table 40. Global Malaria Prescription Medication Sales Share by Application (2024-2034)
Table 41. Global Malaria Prescription Medication Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Malaria Prescription Medication Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Malaria Prescription Medication Revenue Share by Application (2018-2024)
Table 44. Global Malaria Prescription Medication Revenue Share by Application (2024-2034)
Table 45. Malaria Prescription Medication Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Malaria Prescription Medication Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Malaria Prescription Medication Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Malaria Prescription Medication Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Malaria Prescription Medication Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Malaria Prescription Medication Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Malaria Prescription Medication Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Malaria Prescription Medication Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Malaria Prescription Medication Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Malaria Prescription Medication Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Malaria Prescription Medication Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Malaria Prescription Medication Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Malaria Prescription Medication Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Malaria Prescription Medication Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Malaria Prescription Medication Sales by Country (2024-2034) & (K Units)
Table 60. Europe Malaria Prescription Medication Sales by Type (2018-2024) & (K Units)
Table 61. Europe Malaria Prescription Medication Sales by Type (2024-2034) & (K Units)
Table 62. Europe Malaria Prescription Medication Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Malaria Prescription Medication Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Malaria Prescription Medication Sales by Application (2018-2024) & (K Units)
Table 65. Europe Malaria Prescription Medication Sales by Application (2024-2034) & (K Units)
Table 66. Europe Malaria Prescription Medication Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Malaria Prescription Medication Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Malaria Prescription Medication Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Malaria Prescription Medication Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Malaria Prescription Medication Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Malaria Prescription Medication Sales by Country (2018-2024) & (K Units)
Table 72. Europe Malaria Prescription Medication Sales by Country (2024-2034) & (K Units)
Table 73. China Malaria Prescription Medication Sales by Type (2018-2024) & (K Units)
Table 74. China Malaria Prescription Medication Sales by Type (2024-2034) & (K Units)
Table 75. China Malaria Prescription Medication Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Malaria Prescription Medication Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Malaria Prescription Medication Sales by Application (2018-2024) & (K Units)
Table 78. China Malaria Prescription Medication Sales by Application (2024-2034) & (K Units)
Table 79. China Malaria Prescription Medication Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Malaria Prescription Medication Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Malaria Prescription Medication Sales by Type (2018-2024) & (K Units)
Table 82. Asia Malaria Prescription Medication Sales by Type (2024-2034) & (K Units)
Table 83. Asia Malaria Prescription Medication Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Malaria Prescription Medication Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Malaria Prescription Medication Sales by Application (2018-2024) & (K Units)
Table 86. Asia Malaria Prescription Medication Sales by Application (2024-2034) & (K Units)
Table 87. Asia Malaria Prescription Medication Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Malaria Prescription Medication Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Malaria Prescription Medication Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Malaria Prescription Medication Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Malaria Prescription Medication Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Malaria Prescription Medication Sales by Region (2018-2024) & (K Units)
Table 93. Asia Malaria Prescription Medication Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Malaria Prescription Medication Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Malaria Prescription Medication Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Malaria Prescription Medication Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Malaria Prescription Medication Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Malaria Prescription Medication Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Malaria Prescription Medication Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Malaria Prescription Medication Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Malaria Prescription Medication Sales by Country (2024-2034) & (K Units)
Table 107. Zydus Healthcare Company Information
Table 108. Zydus Healthcare Description and Major Businesses
Table 109. Zydus Healthcare Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Zydus Healthcare Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Zydus Healthcare Recent Developments
Table 112. Sun Pharmaceutical Industries Ltd. Company Information
Table 113. Sun Pharmaceutical Industries Ltd. Description and Major Businesses
Table 114. Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 117. Sanofi SA Company Information
Table 118. Sanofi SA Description and Major Businesses
Table 119. Sanofi SA Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi SA Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi SA Recent Developments
Table 122. GSK Plc. Company Information
Table 123. GSK Plc. Description and Major Businesses
Table 124. GSK Plc. Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. GSK Plc. Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GSK Plc. Recent Developments
Table 127. Novartis AG Company Information
Table 128. Novartis AG Description and Major Businesses
Table 129. Novartis AG Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Novartis AG Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novartis AG Recent Developments
Table 132. Cipla Company Information
Table 133. Cipla Description and Major Businesses
Table 134. Cipla Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Cipla Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Cipla Recent Developments
Table 137. Viatris Company Information
Table 138. Viatris Description and Major Businesses
Table 139. Viatris Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Viatris Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Viatris Recent Developments
Table 142. Lupin Company Information
Table 143. Lupin Description and Major Businesses
Table 144. Lupin Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Lupin Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Lupin Recent Developments
Table 147. Advacare Pharma USA Company Information
Table 148. Advacare Pharma USA Description and Major Businesses
Table 149. Advacare Pharma USA Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Advacare Pharma USA Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Advacare Pharma USA Recent Developments
Table 152. VLP Therapeutics Company Information
Table 153. VLP Therapeutics Description and Major Businesses
Table 154. VLP Therapeutics Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. VLP Therapeutics Malaria Prescription Medication Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. VLP Therapeutics Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Malaria Prescription Medication Distributors List
Table 160. Malaria Prescription Medication Customers List
Table 161. Malaria Prescription Medication Market Trends
Table 162. Malaria Prescription Medication Market Drivers
Table 163. Malaria Prescription Medication Market Challenges
Table 164. Malaria Prescription Medication Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Malaria Prescription Medication Product Picture
Figure 2. Global Malaria Prescription Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Malaria Prescription Medication Market Share by Type in 2022 & 2034
Figure 4. Oral and Parenteral Product Picture
Figure 5. Intravenous Product Picture
Figure 6. Global Malaria Prescription Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Malaria Prescription Medication Market Share by Application in 2022 & 2034
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Homecare
Figure 11. Others
Figure 12. Malaria Prescription Medication Report Years Considered
Figure 13. Global Malaria Prescription Medication Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Malaria Prescription Medication Revenue 2018-2034 (US$ Million)
Figure 15. Global Malaria Prescription Medication Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Malaria Prescription Medication Revenue Market Share by Region (2018-2034)
Figure 17. Global Malaria Prescription Medication Sales 2018-2034 ((K Units)
Figure 18. Global Malaria Prescription Medication Sales Market Share by Region (2018-2034)
Figure 19. US & Canada Malaria Prescription Medication Sales YoY (2018-2034) & (K Units)
Figure 20. US & Canada Malaria Prescription Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Malaria Prescription Medication Sales YoY (2018-2034) & (K Units)
Figure 22. Europe Malaria Prescription Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Malaria Prescription Medication Sales YoY (2018-2034) & (K Units)
Figure 24. China Malaria Prescription Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Asia (excluding China) Malaria Prescription Medication Sales YoY (2018-2034) & (K Units)
Figure 26. Asia (excluding China) Malaria Prescription Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Malaria Prescription Medication Sales YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Malaria Prescription Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Malaria Prescription Medication Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Malaria Prescription Medication in the World: Market Share by Malaria Prescription Medication Revenue in 2022
Figure 31. Global Malaria Prescription Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Malaria Prescription Medication Sales Market Share by Type (2018-2034)
Figure 33. Global Malaria Prescription Medication Revenue Market Share by Type (2018-2034)
Figure 34. Global Malaria Prescription Medication Sales Market Share by Application (2018-2034)
Figure 35. Global Malaria Prescription Medication Revenue Market Share by Application (2018-2034)
Figure 36. US & Canada Malaria Prescription Medication Sales Market Share by Type (2018-2034)
Figure 37. US & Canada Malaria Prescription Medication Revenue Market Share by Type (2018-2034)
Figure 38. US & Canada Malaria Prescription Medication Sales Market Share by Application (2018-2034)
Figure 39. US & Canada Malaria Prescription Medication Revenue Market Share by Application (2018-2034)
Figure 40. US & Canada Malaria Prescription Medication Revenue Share by Country (2018-2034)
Figure 41. US & Canada Malaria Prescription Medication Sales Share by Country (2018-2034)
Figure 42. U.S. Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Malaria Prescription Medication Sales Market Share by Type (2018-2034)
Figure 45. Europe Malaria Prescription Medication Revenue Market Share by Type (2018-2034)
Figure 46. Europe Malaria Prescription Medication Sales Market Share by Application (2018-2034)
Figure 47. Europe Malaria Prescription Medication Revenue Market Share by Application (2018-2034)
Figure 48. Europe Malaria Prescription Medication Revenue Share by Country (2018-2034)
Figure 49. Europe Malaria Prescription Medication Sales Share by Country (2018-2034)
Figure 50. Germany Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 51. France Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 52. U.K. Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 53. Italy Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 54. Russia Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 55. China Malaria Prescription Medication Sales Market Share by Type (2018-2034)
Figure 56. China Malaria Prescription Medication Revenue Market Share by Type (2018-2034)
Figure 57. China Malaria Prescription Medication Sales Market Share by Application (2018-2034)
Figure 58. China Malaria Prescription Medication Revenue Market Share by Application (2018-2034)
Figure 59. Asia Malaria Prescription Medication Sales Market Share by Type (2018-2034)
Figure 60. Asia Malaria Prescription Medication Revenue Market Share by Type (2018-2034)
Figure 61. Asia Malaria Prescription Medication Sales Market Share by Application (2018-2034)
Figure 62. Asia Malaria Prescription Medication Revenue Market Share by Application (2018-2034)
Figure 63. Asia Malaria Prescription Medication Revenue Share by Region (2018-2034)
Figure 64. Asia Malaria Prescription Medication Sales Share by Region (2018-2034)
Figure 65. Japan Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 66. South Korea Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 67. China Taiwan Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 68. Southeast Asia Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 69. India Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Malaria Prescription Medication Sales Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Malaria Prescription Medication Revenue Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Malaria Prescription Medication Sales Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Malaria Prescription Medication Revenue Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Malaria Prescription Medication Revenue Share by Country (2018-2034)
Figure 75. Middle East, Africa and Latin America Malaria Prescription Medication Sales Share by Country (2018-2034)
Figure 76. Brazil Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 77. Mexico Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 78. Turkey Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 79. Israel Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 80. GCC Countries Malaria Prescription Medication Revenue (2018-2034) & (US$ Million)
Figure 81. Malaria Prescription Medication Value Chain
Figure 82. Malaria Prescription Medication Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed